Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Malignant Neoplasm to Brain”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07623577
What this trial is testing

Sac-TMT Combined With Bevacizumab in TNBC With Brain Metastases

Who this might be right for
TNBCBrain Metastasis
Fudan University 24
Testing effectiveness (Phase 2)Study completedNCT03526900
What this trial is testing

Atezolizumab in Combination With Carboplatin Plus Pemetrexed in Chemotherapy-naïve Patients With Asymptomatic Brain Metastasis

Who this might be right for
Non-small Cell Lung Cancer Stage IV
Spanish Lung Cancer Group 40
Not applicableStudy completedNCT00255671
What this trial is testing

Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders

Who this might be right for
Brain and Central Nervous System TumorsMetastatic CancerRadiation Toxicity
Case Comprehensive Cancer Center 76
Testing effectiveness (Phase 2)Looking for participantsNCT07505173
What this trial is testing

Hippocampus-Protective Radiotherapy Combined With Osimertinib for Symptomatic Brain Metastases in EGFR-Mutated Lung Cancer

Who this might be right for
Naive Advanced Non-small Cell Lung Cancer With EGFR-sensitive Mutations (EGFR Exon 19 Deletion and Exon 21 L858R Mutation) and Symptomatic Brain Metastases
Tianjin Medical University Cancer Institute and Hospital 74
Very early researchWithdrawnNCT05054400
What this trial is testing

Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MR

Who this might be right for
Brain MetastasesCancerGliomas+1 more
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00617539
What this trial is testing

Irinotecan and Temozolomide in Treating Patients With Breast Cancer Who Have Received Previous Treatment for Brain Metastases

Who this might be right for
Breast CancerMetastatic Cancer
University of California, San Francisco 30
Testing effectiveness (Phase 2)Looking for participantsNCT07462507
What this trial is testing

Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1

Who this might be right for
Central Nervous System CancerBrain Metastases
Washington University School of Medicine 104
Not applicableUnknownNCT00938756
What this trial is testing

Study of Cerebrospinal Fluid Samples in Diagnosing Carcinomatous Meningitis in Patients With Cancer or Meningeal Syndrome

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerMetastatic Cancer
Centre Oscar Lambret 80
Not applicableUnknownNCT03617341
What this trial is testing

Brain Monitoring for High Risk of Brain Metastases in Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer With HER2 PositiveTriple Negative Breast Cancer
Yonsei University 200
Early research (Phase 1)Looking for participantsNCT02390518
What this trial is testing

Stereotactic Radiosurgery Dose Escalation for Brain Metastases

Who this might be right for
Brain Metastases
University of Utah 86
Not applicableStudy completedNCT01705548
What this trial is testing

Hypofractionated Stereotactic Radiosurgery in Treating Patients With Large Brain Metastasis

Who this might be right for
Metastatic Malignant Neoplasm to BrainUnspecified Adult Solid Tumor, Protocol Specific
Emory University 24
Testing effectiveness (Phase 2)Study completedNCT02048059
What this trial is testing

ANG1005 in Breast Cancer Patients With Recurrent Brain Metastases

Who this might be right for
Breast CancerBrain Metastases
Angiochem Inc 72
Testing effectiveness (Phase 2)UnknownNCT05042791
What this trial is testing

Pyrotinib Plus Capecitabine Combined With SRT in HER2+ MBC With Brain Metastases

Who this might be right for
HER2-positive Metastatic Breast Cancer
Jiangxi Provincial Cancer Hospital 362
Not applicableActive Not RecruitingNCT06649591
What this trial is testing

Expert Consensus and Artificial Intelligence in Medical Decision Making in Patients with Malignant Brain Tumors

Who this might be right for
Malignant Brain Tumors
Tufts Medical Center 225
Testing effectiveness (Phase 2)Study completedNCT04345146
What this trial is testing

Bevacizumab Combined With Fractionated Stereotactic Radiotherapy for 1 to 10 Brain Metastases From NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 100
Early research (Phase 1)Study completedNCT00049023
What this trial is testing

Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsGastrointestinal Carcinoid TumorIslet Cell Tumor+4 more
O'Dorisio, M S 27
Not applicableUnknownNCT04626206
What this trial is testing

Multi -paramEtric Imaging to Assess Treatment REsponse After Stereotactic Radiosurgery of Brain Metastases

Who this might be right for
Brain Metastases, Adult
Royal Marsden NHS Foundation Trust 12
Testing effectiveness (Phase 2)WithdrawnNCT05620914
What this trial is testing

A Window of Opportunity Study of Patritumab Deruxtecan in Patients With Brain Metastases

Who this might be right for
Brain Metastases, Adult
Mustafa Khasraw, MBChB, MD, FRCP, FRACP
Not applicableUnknownNCT01798771
What this trial is testing

Intraoperative MRI and 5-ALA Guidance to Improve the Extent of Resection in Brain Tumor Surgery

Who this might be right for
Primary Malignant Neoplasm of Nervous SystemGliomaGlioblastoma+1 more
Johann Wolfgang Goethe University Hospital 108
Early research (Phase 1)Looking for participantsNCT06136884
What this trial is testing

A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases

Who this might be right for
Solid Tumor MalignanciesBrain Metastases From Solid Tumors
A2A Pharmaceuticals Inc. 86
Next Page